| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.16B | 99.97B | 96.34B | 88.06B | 97.97B | 94.02B |
| Gross Profit | 16.27B | 19.58B | 15.84B | 14.08B | 12.54B | 13.29B |
| EBITDA | 10.75B | 14.22B | 9.44B | 8.49B | 7.17B | 8.93B |
| Net Income | 7.21B | 11.66B | 6.42B | 5.38B | 3.12B | 5.23B |
Balance Sheet | ||||||
| Total Assets | 132.82B | 152.56B | 131.16B | 136.40B | 124.36B | 132.87B |
| Cash, Cash Equivalents and Short-Term Investments | 3.51B | 5.09B | 3.44B | 3.91B | 3.57B | 29.31B |
| Total Debt | 34.39B | 32.60B | 36.47B | 39.54B | 43.31B | 54.06B |
| Total Liabilities | 66.98B | 70.31B | 66.51B | 74.17B | 73.24B | 84.85B |
| Stockholders Equity | 65.84B | 82.25B | 64.65B | 62.23B | 50.96B | 47.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.46B | -1.38B | -4.51B | 5.42B | 11.95B |
| Operating Cash Flow | 0.00 | 8.00B | 1.45B | -2.48B | 7.15B | 14.51B |
| Investing Cash Flow | 0.00 | -1.21B | -1.72B | -1.44B | -1.58B | -2.64B |
| Financing Cash Flow | 0.00 | -4.61B | -3.56B | -4.00B | -11.43B | -3.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥34.77B | 9.39 | ― | 2.74% | 9.38% | 49.37% | |
75 Outperform | ¥15.93B | 10.34 | ― | 2.02% | 22.62% | 180.38% | |
74 Outperform | ¥20.70B | 27.79 | ― | 2.78% | 5.18% | 37.11% | |
70 Outperform | ¥63.01B | 12.68 | 11.47% | 1.88% | -0.81% | 28.73% | |
68 Neutral | ¥48.06B | 4.08 | 16.07% | 1.07% | 3.77% | 81.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥72.70B | 15.17 | ― | 0.55% | 2.93% | 10.00% |